GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

The integration of Artificial Intelligence (AI) in drug discovery is rapidly transforming the pharmaceutical industry.

Google DeepMind CEO Demis Hassabis, one of the only people in the world with a Nobel Prize for work on artificial ...

As per Vantage Market Research, the Global Artificial Intelligence in the Drug Discovery Market has been steadily growing ...

Artificial intelligence is increasingly becoming a cornerstone in pharmaceutical research, with numerous companies leveraging ...

As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not ...

If things continue moving at this pace, the next decade could see AI playing a major role in curing diseases we once thought ...

At Google DeepMind, researchers are chasing what's called artificial general intelligence: a silicon intellect as versatile as a human's, but with superhuman speed and knowledge.

Profluent has announced ProGen3, a new family of artificial intelligence (AI) models capable of designing complex proteins ...

Absci Corporation’s ABSI share price has surged by 5.86%, which has investors questioning if this is right time to sell.

Honeywell has launched an artificial intelligence-assisted, cloud-native platform with an aim to transform the way in which ...

The global AI-enabled drug discovery and clinical trials market size is estimated to reach USD 1,599 by 2030 from 2019 with a CAGR of 24%. The clinical guidelines are not uniform across the studied ...